Skip to content
Search AI Powered

Latest Stories

Bluntness Q&A with Paul Botto of Lucid Green

Bluntness Q&A with Paul Botto of Lucid Green

Sign Up for The Bluntness Newsletter for Your Weekly Dose of Cannabis News


When buying your cannabis, who can you trust? The New York-based startup Lucid Green is hoping it’s them. “This is a trust and transparency platform,” says company co-founder and president Paul Botto. “Every brand wants to deliver the safest, most predictable, most enjoyable experience. But very few have found ways to actually deliver upon that so we are giving them a platform.” Botto describes Lucid Green’s web app system as being built for the cannabis consumer who thinks, “I want to buy a product, and I don’t want to roll the dice every time I try something new.”



Through Lucid Green, dispensary customers can point their camera phones at scan codes on affiliated products and be instantly linked to deep-dive info compiling their proper dosage, expected effects, and recorded testing results. The platform also provides dashboard tools to track how high that gummy might have made them and earn loyalty rewards for their favorite brands. With time spent in the data mines at Google, Botto brings a calibrated sense of how much data is too much. (“One of the things I learned [at Google Analytics] was that just dumping mountains of data on people can be more debilitating than not having any data at all,” he says.)


Revenue comes from cannabis brands, who pay Lucid Green to put the codes on their packaging and provided the info stash on the other end. They can also use the platform to remotely train dispensary budtenders on brand particulars, and track how often that leads to increased sales. Eventually, the company theorizes that customers will learn to associate LG affiliates with a higher standard of trustworthiness and predictability of effect, which will brands will then translate into loyal customers and increased sales.


The platform is now up and running in dispensaries across California and Colorado, and poised to go big in newly legal Illinois, taking what Botto terms as a “land and expand approach” aimed at landing a sub-section of real estate in every dispensary in states where they are operating, rather than breaking into every state market as quick as possible.


We talked to Botto about Lucid Green’s plan to provide clarity to consumers and value to brands, how a key tweak to their service that came from dispensary feedback, and the vital importance of budtenders in the cannabis industry eco-system.


Lucid Green seeks to provide all sides of the supply chain with accurate information, analytics, and greater transparency. What’s otherwise complicating that process for the cannabis industry right now?


It’s a pretty convoluted system. There are a lot of stops along the way for a product to get in the hands of a consumer. And because of the lack of federal oversight, there really isn’t a standard with which people have adopted on how to actually deliver an accurate representation about what’s in your hand. It’s different from state to state, and the requirements usually include, for example, testing a product. However, what tests are required can be vastly different from state to state, right?


If you’re from Maryland you go to Vegas on vacation, you might expect the cannabis that you are buying in Nevada to be exactly the same in terms of what they test for, and what’s an allowable trace amount of pesticides or microorganisms or whatever. So if you are allergic to trace amounts of pesticides, you’re totally fine in your home market, you go somewhere else and you might really put yourself in danger. That’s an extreme example, but it’s still important for people to have predictability and understand how this thing is going to affect them.


What we’re trying to do is take disparate data stacks that are locked up in seed to sale systems, locked up in product development marketing information, locked up in customer feedback or reviews, in all these various places, and bring them together and make them available on a package that really has no room for this information. It’s not that the brands don’t want to share this info, in large part they just have nowhere to put it. The package is filled with regulatory requirements that don’t necessarily guide the consumer in the right way.


How long did it take you to come up with a consistent, user-friendly platform that compiled such a sprawling set of information?


It took us about a year to develop the product to a point where we were comfortable getting out into the market. There’s a philosophy here that I sort of borrowed from my Google days of release early and release often. You think you know what people want, but you don’t know until you give it to them. Only once you get it in their hands, do you really start iterating. I would say that’s an ongoing process and I expect to be doing that forever.


What feedback have you gotten that’s led to a direct tweak of the platform?


There’s been quite a few of those. One example is, at the onset when we first released, we allowed brands to deliver loyalty tokens that customers could use to then go back in to buy more product. Early on, we had these tokens pegged to the dispensaries. We thought that “Hey, the consumers are going to be earning some value here, and they need a place to go spend it.” It turned out that the dispensaries were like, we love the platform, but you had me right up until “log into your dashboard” (laughs) The additional layer was, “We already have a loyalty program, and you’re kind of creating a redundant loyalty program.”


So, we aimed those tokens back to the brands. If I’m Wana, the customer earns Wana-tokens that can only be spent on [Wana brand] products. And we flipped it to now you can go to any dispensary you want, and use your Wana tokens. That was a big change for us, a pretty substantive change, and it came directly from brand feedback and dispensary feedback. It almost seems painfully obvious now, but we had to get out in the market to understand that.


Do you think that cannabis brands have been a little slow to embrace the importance of budtenders as folks that they should be actively and aggressively marketing to?


I don’t think that’s a lack of interest in doing that, I think it’s a lack of opportunity. What [brands] do now is they send human beings, onboarding teams, to stand in front of the budtenders and talk to them. It’s better than nothing, but it’s really really difficult to do, and it’s enormously expensive. It’s almost impossible to track. Who was at that meeting? Who actually got it and can repeat it? How do you measure that when you stand in front of these guys for 20 minutes in their pre-dawn meeting, half the team is eating breakfast when you’re talking. You have these onboarding teams for the brands who are like, “Yeah, I trained 75 percent of the dispensaries in Colorado,” but in reality, only 35 percent of budtenders were there, or understood it, or can pass on information. And that’s probably being generous.


We give them a scalable, accountable way to train budtenders. In real time, they can look in their data and see at this time we have eight budtenders that have taken the training, passed the quiz, and are actively driving scans. Those are metrics that go layer by layer into how well your onboarding team did their job. The other way to do it is, as an alternative to sending a human being out there, you contact the dispensary, you email and just say, “Hey guys, go on to the Lucid Green platform, take our training and there you go.” It’s hard for brands to improve upon budtender activation if you don’t know how well you are doing right now. That’s what we are trying to bring to the market.


How do you measure your progress towards your stated goal of becoming a “Single Source of Truth” in the cannabis industry? What are your benchmarks?


We can measure success very, very simply. The number of integrated products in market, and the number of scans and engagement with those products. Our business is dead simple in terms of measuring success. It’s really those two numbers. The dispensaries come on board as a consequence of brands having integrated product on the shelf of the dispensary, so one drives the other.

Our goal is really to have some percentage of every dispensary shelf stocked with integrated products. We believe that the value of this information will actually start to drive purchase decisions. I’ll look at the shelf, I’ll see Lucid Green codes and maybe a couple products next to it without the code, and I’ll go with the one that has the code on it.

More For You

Ranking Magic Mushrooms by Potency
Ranking Magic Mushrooms by Potency
Tripsitter

Shroom Showdown: Ranking Magic Mushrooms by Potency

From  Psilocybe azurescens to Psilocybe cubensis   — the potency of magic mushrooms varies greatly.

A single gram of one species is enough to shift reality on its axis — the same amount of another may be barely perceptible.

Keep ReadingShow less
THCV's benefits are compelling, however people have a hard time finding high-THCV cannabis cultivars.
THCV's benefits are compelling, however people have a hard time finding high-THCV cannabis cultivars.
Photo by Sharon McCutcheon from Pexels

The Ultimate Guide to THCV Strains

THC and CBD are undoubtedly the two “star” cannabinoids almost everyone knows about. But the cannabis plant, with its complexity and rich spectrum, contains many more lesser-known chemicals. While researchers find something new every day, so far we know that the cannabis plant produces at least 80-100 cannabinoids and over 300 non-cannabinoid substances. 

THCV - or Tetrahydrocannabivarin - is one of those cannabinoids that are packed with benefits and yet still relatively unutilized. Here is all you need to know about this cannabinoid - and some tips to find the best THCV strains. 

Keep ReadingShow less
The Holistic Health Benefits of Cannabis - The Bluntness

Th Holistic Health Benefits of Cannabis

Cannabis for Holistic Health

As the dialogue around holistic health continues to expand, cannabis is stepping into the spotlight, now recognized not only for its recreational uses but also as a potential enhancer of wellness. What if the ancient herb that once held a pivotal place in traditional medicine is now a key to modern wellness practices? This exploration focuses on improving the quality of life. How does this age-old plant interact with the body to potentially ease pain, enhance sleep, and improve mental health?

With a surge in both curiosity and scientific research, cannabis is being revisited by wellness advocates and skeptics alike. How do THC, CBD, and other cannabinoids actually affect our bodies? What are the real stories behind the people incorporating cannabis into their daily wellness routines? From the science of its effects to the practicalities of choosing the right products, this discussion examines how cannabis is being used to potentially foster a healthier, more balanced lifestyle.

Keep ReadingShow less
A classic case of botrytis a.k.a bud rot. Moldy cannabis should never be inhaled or smoked.
A classic case of botrytis a.k.a bud rot. Moldy cannabis should never be inhaled or smoked.

Smoking Moldy Weed and How It Can Make You Sick

Cannabis may have a robust safety profile with zero fatal overdoses on record, however smoking moldy weed can pose a serious risk to human health.

While you might have thought mold was reserved for unkempt showers or perishable food items, unwanted fungi can grow in your stash if you’re not careful. 

Keep ReadingShow less
How Cannabis is Easing Dementia Symptoms and Changing Lives - The Bluntness
How Cannabis is Easing Dementia Symptoms and Changing Lives - The Bluntness
Photo by Steven HWG on Unsplash

Cannabis: A New Hope for Dementia Care

For decades, dementia has been a formidable challenge for patients, caregivers, and healthcare providers alike. Characterized by anxiety, agitation, and a decline in cognitive function, the disease often leaves loved ones and medical professionals searching for ways to improve patients’ quality of life. Enter cannabis—a once-stigmatized plant now emerging as a potential game-changer for dementia care.

While definitive research is limited, anecdotal evidence and early studies are painting a promising picture of cannabis as a tool for managing symptoms like anxiety, agitation, and sleep disturbances. For patients like 72-year-old Mark Roberts of Elwell, Michigan, cannabis has provided relief traditional medications failed to deliver. “It just calms me down,” he shared with the Wall Street Journal, of the liquid cannabis dose he takes twice a day. His wife Brenda agrees, noting in the article how the treatment has positively impacted their relationship by easing his outbursts and anxiety.

Keep ReadingShow less